PTX 7.32% 4.4¢ prescient therapeutics limited

Ann: PTX-100 Ph1b results show excellent safety & efficacy in TCL, page-33

  1. 7,858 Posts.
    lightbulb Created with Sketch. 3351
    Thanks Lance. I agree that the swimmers plot doesn't look to be accurate (in places). Maybe they left that data to the graphics dept to interpret and adjust accordingly... if so, they should be crucified.

    According to all other information there is no reason to be disappointed with the data. It's interesting to read the following statements re Mean vs Median PFS:-

    FROM MARCH RESULTS THIS YEAR:-

    https://hotcopper.com.au/data/attachments/5810/5810377-e7043b00ff7ecec3d5960c2b6750fc8a.jpg
    https://hotcopper.com.au/data/attachments/5810/5810418-b82f82aeeb2b6b17d7e1016cb1bc9cda.jpg



    FROM TODAY'S ANN:-

    We have exceeded what's considered as a target benchmark for a Phase 2 or registrational study based on PFS duration by a long way-

    https://hotcopper.com.au/data/attachments/5810/5810431-bee179f9924d63d931d07eea4872d7b8.jpg



    https://hotcopper.com.au/data/attachments/5810/5810436-e0bd307c2b870788ff40cc2a626afb85.jpg
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.